ZA964508B - Tricyclic inhibitors of matrix metalloproteinases - Google Patents
Tricyclic inhibitors of matrix metalloproteinasesInfo
- Publication number
- ZA964508B ZA964508B ZA964508A ZA964508A ZA964508B ZA 964508 B ZA964508 B ZA 964508B ZA 964508 A ZA964508 A ZA 964508A ZA 964508 A ZA964508 A ZA 964508A ZA 964508 B ZA964508 B ZA 964508B
- Authority
- ZA
- South Africa
- Prior art keywords
- matrix metalloproteinases
- gelatinase
- inhibitors
- tricyclic inhibitors
- tricyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/460,437 US5627206A (en) | 1995-06-02 | 1995-06-02 | Tricyclic inhibitor of matrix metalloproteinases |
| US08/460,436 US5665764A (en) | 1995-06-02 | 1995-06-02 | Tricyclic inhibitors of matrix metalloproteinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA964508B true ZA964508B (en) | 1996-12-09 |
Family
ID=27039692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA964508A ZA964508B (en) | 1995-06-02 | 1996-05-31 | Tricyclic inhibitors of matrix metalloproteinases |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0828726B1 (de) |
| JP (1) | JPH11506097A (de) |
| KR (1) | KR19990022171A (de) |
| AT (1) | ATE206416T1 (de) |
| AU (1) | AU717570B2 (de) |
| CA (1) | CA2220040A1 (de) |
| DE (1) | DE69615680T2 (de) |
| DK (1) | DK0828726T3 (de) |
| ES (1) | ES2165496T3 (de) |
| MX (1) | MX9708728A (de) |
| PT (1) | PT828726E (de) |
| WO (1) | WO1996038434A1 (de) |
| ZA (1) | ZA964508B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ333063A (en) * | 1996-09-04 | 2000-12-22 | Warner Lambert Co | Dibenzofuran sulfonamide derivatives as matrix metalloproteinase inhibitors |
| JP2002514180A (ja) | 1996-09-04 | 2002-05-14 | ワーナー―ランバート・コンパニー | マトリックスメタロプロテイナーゼを阻害するための化合物およびその方法 |
| US6624177B1 (en) | 1996-09-04 | 2003-09-23 | Warner-Lambert Company | Matrix metalloproteinase inhibitors and their therapeutic uses |
| NZ334897A (en) * | 1996-12-09 | 2001-02-23 | Warner Lambert Co | Medicaments for treating and preventing heart failure and ventricular dilatation |
| ES2212142T3 (es) | 1996-12-17 | 2004-07-16 | Warner-Lambert Company Llc | Uso de inhibidores de metaloproteinasas de la matriz para promover la curacion de heridas. |
| SI0946166T1 (en) * | 1996-12-17 | 2004-06-30 | Warner-Lambert Company Llc | Use of matrix metalloproteinase inhibitors for promoting wound healing |
| US6399612B1 (en) | 1997-10-06 | 2002-06-04 | Warner-Lambert Company | Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| US6350885B1 (en) | 1998-07-30 | 2002-02-26 | Warner-Lambert Company | Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases |
| OA11589A (en) | 1998-07-30 | 2004-07-30 | Warner Lambert Co | Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases. |
| DOP2002000334A (es) * | 2001-02-14 | 2002-08-30 | Warner Lambert Co | Pirimidinas biciclicas como inhibidores de metaloproteinasas de matriz |
| AU2003253150A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Chromone derivatives as matrix metalloproteinase inhibitors |
| SI2074093T1 (sl) * | 2006-08-22 | 2012-12-31 | Ranbaxy Laboratories Limited | Postopek za pridobitev inhibitorjev matrične metalproteinaze in kiralni pomožnik zanj |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3649651A (en) * | 1969-07-02 | 1972-03-14 | American Home Prod | Dibenzofuran derivatives and preparation thereof |
| US5326760A (en) * | 1992-06-29 | 1994-07-05 | Glaxo, Inc. | Aminobutanoic acid compounds having metalloprotease inhibiting properties |
-
1996
- 1996-04-26 PT PT96913185T patent/PT828726E/pt unknown
- 1996-04-26 AT AT96913185T patent/ATE206416T1/de not_active IP Right Cessation
- 1996-04-26 MX MX9708728A patent/MX9708728A/es not_active IP Right Cessation
- 1996-04-26 JP JP8536475A patent/JPH11506097A/ja not_active Abandoned
- 1996-04-26 KR KR1019970708650A patent/KR19990022171A/ko not_active Application Discontinuation
- 1996-04-26 EP EP96913185A patent/EP0828726B1/de not_active Expired - Lifetime
- 1996-04-26 WO PCT/US1996/005830 patent/WO1996038434A1/en not_active Application Discontinuation
- 1996-04-26 AU AU55777/96A patent/AU717570B2/en not_active Ceased
- 1996-04-26 DE DE69615680T patent/DE69615680T2/de not_active Expired - Fee Related
- 1996-04-26 ES ES96913185T patent/ES2165496T3/es not_active Expired - Lifetime
- 1996-04-26 DK DK96913185T patent/DK0828726T3/da active
- 1996-04-26 CA CA002220040A patent/CA2220040A1/en not_active Abandoned
- 1996-05-31 ZA ZA964508A patent/ZA964508B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996038434A1 (en) | 1996-12-05 |
| ATE206416T1 (de) | 2001-10-15 |
| AU717570B2 (en) | 2000-03-30 |
| EP0828726B1 (de) | 2001-10-04 |
| DK0828726T3 (da) | 2002-01-21 |
| DE69615680T2 (de) | 2002-07-11 |
| CA2220040A1 (en) | 1996-12-05 |
| ES2165496T3 (es) | 2002-03-16 |
| JPH11506097A (ja) | 1999-06-02 |
| MX9708728A (es) | 1997-12-31 |
| AU5577796A (en) | 1996-12-18 |
| EP0828726A1 (de) | 1998-03-18 |
| DE69615680D1 (de) | 2001-11-08 |
| KR19990022171A (ko) | 1999-03-25 |
| PT828726E (pt) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL123901A (en) | Sulfonamide inhibitors of matrix metalloproteinases and pharmaceutical compositions comprising them | |
| ZA964508B (en) | Tricyclic inhibitors of matrix metalloproteinases | |
| NZ509439A (en) | Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases | |
| ZA9610722B (en) | Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases | |
| FI953139A0 (fi) | Atovakonia käsittäviä farmaseuttisia koostumuksia | |
| NO972980D0 (no) | Anvendelse av nebivolol som et anti-aterogent middel | |
| HUP9802762A2 (hu) | Difenil-metilén-piperidin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
| NO944448D0 (no) | Nye farmasöytiske anvendelser av krill-enzymer | |
| RU1833372C (ru) | Cпocoб пoлучehия пpoизboдhыx 2,4,5-зameщehhыx бehзoлa | |
| BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| CA2233560A1 (en) | Sulfonamide inhibitors of matrix metalloproteinases | |
| AP9701142A0 (en) | 4,4-(Disubstituted) cyclohexan-1-ols monomers and related compounds. |